Total funding allocated to projects this organisation participated or coordinated
Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.
Total number of projects: 8
As coordinator: 0
As participant: 8
Sole participant: 0
Coordinator / Participant Ratio: 0*
*Ratio includes only projects with > 2 partners
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 29.980.670 | 566.985 | 1 | ||
2010 | 0 | 23.966.071 | 636.757 | 2 | ||
2008 | 0 | 11.989.327 | 428.190 | 1 | ||
2007 | 0 | 2.985.102 | 331.678 | 1 | ||
2006 | 0 | 7.997.720 | 296.212 | 1 | ||
2004 | 0 | 21.905.986 | 651.556 | 2 |
Total number of partners:2506
Partner loyalty:
Frequent Partner: (> 2 projects): 914
Rare Partner: 1592
Frequent / Rare Partner Ratio: 0.57
Category: | No: |
---|---|
RTD HORIZONTAL TOPICS | 75 |
SOCIAL AND ECONOMIC CONCERNS | 51 |
INDUSTRY AND TECHNOLOGY | 49 |
BIOLOGICAL SCIENCES | 16 |
PROTECTING MAN AND HIS ENVIRON | 9 |
PHYSICAL AND EXACT SCIENCES | 8 |
AGRICULTURE AND MARINE RESOURC | 2 |
ENERGY | 2 |
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-10-01 | Advanced Immunization Technologies | ADITEC | participant | 29.980.670 | 52 |
2010-10-01 | Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses | SILVER | participant | 12.000.000 | 24 |
2010-01-01 | Construction kit for tailor-made vascularized boneimplants | VascuBone | participant | 11.966.071 | 18 |
2008-04-01 | European Study to Establish Biomarkers of Human Ageing | MARK-AGE | participant | 11.989.327 | 28 |
2007-03-01 | Colon and breast cancer diagnostics | COBRED | participant | 2.985.102 | 9 |
2006-10-01 | Nanoscale Functionalities for Targeted Drug Delivery of Biopharmaceutics | NANOBIOPHARMACEUTICS | participant | 7.997.720 | 27 |
2004-11-01 | Comparative structural genomics of viral enzymes involved in replication | VIZIER | participant | 12.905.986 | 26 |
2004-05-01 | European Vigilance Network for the Management of Antiviral Drug Resistance | VIRGIL | participant | 9.000.000 | 58 |